Article

Biotherapeutics.

Imperial College of Science, Technology and Medicine, UK.
Drug News & Perspectives (impact factor: 2.21). 07/2008; 21(5):290-6. pp.290-6
Source: PubMed

ABSTRACT This Society for Medicines Research symposium was held on March 6, 2008, at the National Heart and Lung Institute, London, U.K. The meeting, organized by Kate Brown and David Fox reviewed the state-of-the-art in biotherapeutics. This is an area that is acquiring increasing importance in drug discovery and development portfolios, offering new and alternative ways of treating a wide range of conditions as well as opening up new and exciting areas of science and technology. Presentations ranged from the therapeutic potential of monoclonal and polyclonal antibodies, vaccines and oligonucleotides, through to the scientific basis of the emerging area of RNA interference. In addition, some of the technical aspects of delivering novel therapies and ensuring their quality were also discussed.

0 0
 · 
0 Bookmarks
 · 
23 Views

Keywords

alternative ways
 
conditions
 
David Fox
 
drug discovery
 
emerging area
 
exciting areas
 
Kate Brown
 
Lung Institute
 
March 6
 
Medicines Research symposium
 
monoclonal
 
novel therapies
 
offering new
 
polyclonal antibodies
 
Presentations
 
RNA interference
 
scientific basis
 
technical aspects
 

Katherine Brown